Antifungal medication :: Consumers survey results of 2011

Consumers survey results of 2011 in category

Dermatology, means for external use / Antifungal medication

The annual ratings by results of Consumers survey calculated as average arithmetic mean rank, obtained in each of 4 quarters of year.

	I quarter (january—march)
	II quarter (april—june)
	III quarter (july—september)
	IV quarter (october—december)

1.		Lamisil (Novartis OTC)	45.65%	5

2.		Кандібене (ratiopharm)	18.84%	2.17

3.		Lamikon (Farmak)	18.12%	2.02

4.	5	Клотримазол (Борщагівський ХФЗ)	16.67%	1.97

5.	20	Флуконазол (Pharmaceutical company “Zdorovya”)	16.67%	1.82

6.	4	Екзодерил (Sandoz)	17.39%	1.79

7.	10	Нітрофунгін (Teva)	11.59%	1.54

8.	6	Кетоконазол (Фітофарм)	13.04%	1.344

9.	24	Клотримазол (ORGANOSYN)	12.32%	1.341

10.	7	Клотримазол Гексал (Sandoz)	11.59%	1.339

11.		Мікогал (Teva)	10.14%	1.242

12.	13	Флюконазол (Norton)	9.42%	1.225

13.	22	Флуконазол (Red star)	9.42%	1.156

14.	25	Клотримазол-Фітофарм (Фітофарм)	8.70%	1.014

15.	8	Міконазол-Дарниця (Darnitsa)	10.14%	0.994

16.	19	Мікосист (Gedeon Richter)	6.52%	0.839

17.		Мікоспор (Bayer)	5.80%	0.813

18.	26	Антифунгін (Монфарм)	5.80%	0.760

19.	12	Теймурова паста (Ternopharm)	8.70%	0.753

20.	16	Мікосептин (Zentiva)	7.97%	0.711

21.		Клотрисал-КМП (Arterium Corporation)	4.35%	0.588

22.	23	Екодакс (Johnson & Johnson)	2.90%	0.582

23.	27	Травоген (Bayer)	5.07%	0.565

24.	22	Мікомакс (Zentiva)	5.80%	0.512

25.	23	Мікогель-КМП (Arterium Corporation)	3.62%	0.473

26.	8	Міфунгар (Zentiva)	4.35%	0.426

27.	29	Zalain (Egis Pharmaceuticals)	5.80%	0.387

28.	18	Viosept (Jelfa)	3.62%	0.364

–.	9	~~Ундецин (Arterium Corporation)~~	~~2.17%~~	~~0.310~~

29.	25	Канестен (Bayer)	2.90%	0.294

29.	18	Міконазол (Elegant India)	2.90%	0.294

31.	28	Еконазол (Red star)	2.17%	0.171

31.	15	Тримістин-Дарниця (Darnitsa)	2.17%	0.171

33.	14	Фунготербін (Nizhpharm)	1.45%	0.109

34.	27	Тербінокс (Johnson & Johnson)	1.45%	0.093

–.		Міконазол Гексал (Sandoz)	0.00%	0

–.		Флуконазол (Vitaminy)	0.00%	0

–.		Флуконазол (Астрафарм)	0.00%	0

–.		Цинкундан (Arterium Corporation)	0.00%	0

The participant which took the 1st place in this rating is by opinion of Ukrainian consumers is the best choice in 2011, recommendation of consumers #1 in the category “Antifungal medication”.

Using this rating is only possible with obligatory link to the source.

This rating was built as a result of the study of social preferences in 2011, under the “Favorites of Success” Contest in Ukraine and it’s the free information. In case of full or partial republishing of the information drawn from this rating, it is obligatory to mention the name of the “Favorites of Success” Contest in printed publications, or put an active hyperlink to this page in the electronic media.

Advanced reporting booklet about the study, including demographics of the respondents, by regional breakdown, information roll-call of ad hoc judges etc, can also be obtained from managers of the contest.